NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/22/2026
Back to search
Official data from USPTO
OTC PHARMA PF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OTC PHARMA PF
ST13
US500000078712471Class
5
Filing
78712471
Registration
3157497
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/16/2026
Trademark type
Word
Nice classes
5
Filing date
09/14/2005
Registration date
10/17/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/22/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/27/1990
First use in commerce
05/02/1991
Drawing code
4
Owner type
03
Owner location
Miami, FL, US
Examiner
SOMERVILLE, ARETHA CHARESE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Benard Industries, Inc.
Representatives
John Cyril Malloy, III MALLOY & MALLOY, P.L.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
vitamin and mineral supplements
Publications
History of USPTO decisions and trademark events.
27 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/22/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/22/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/17/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
12/06/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/06/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/06/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/06/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
09/26/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
05/30/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/30/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/30/2012
E815
TEAS SECTION 8 & 15 RECEIVED
05/18/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
10/17/2006
PUBO
PUBLISHED FOR OPPOSITION
08/01/2006
NPUB
NOTICE OF PUBLICATION
07/12/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/14/2006
ALIE
ASSIGNED TO LIE
06/09/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/19/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2006
PAPER RECEIVED
05/05/2006
CNRT
NON-FINAL ACTION MAILED
03/24/2006
CNRT
NON-FINAL ACTION WRITTEN
03/23/2006
DOCK
ASSIGNED TO EXAMINER
03/23/2006
NWAP
NEW APPLICATION ENTERED
09/21/2005
Continuous trademark protection
Get notified about every new filing that threatens OTC PHARMA PF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.